Table 1 Multivariate prognostic model containing 14 survival-associated AS events.

From: Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study

Id

Coef

HR

P value

CSAD|21962|ES

 − 4.174

0.015389

4.60E−05

MASP2|636|AT

 − 4.564

0.010416

2.87E−05

HNRNPM|94942|ES

 − 5.956

0.00259

0.052207

RAB5B|22326|AP

 − 5.513

0.004034

0.029795

FBXO28|9933|ES

 − 18.986

5.68E−09

0.005594

ITPR1|63015|ES

 − 56.278

3.62E−25

4.06E−06

HERC4|11918|ES

 − 32.543

7.36E−15

1.49E−06

ZNF586|52337|AT

4.934

138.9373

0.003321

C6orf141|76449|AT

0.981

2.666126

0.034518

EPHX2|83166|ES

 − 16.046

1.08E−07

0.001239

SUV420H1|17300|ES

 − 9.282

9.31E−05

0.003428

NKG7|51323|ES

 − 168.188

9.06E−74

0.001175

LPXN|16012|ES

 − 6.593

0.001369

7.76E−05

SLC37A3|81990|ES

 − 11.881

6.92E−06

0.001907